10QSB 1 d10qsb.htm FORM 10-QSB Form 10-QSB
Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


Form 10-QSB

 


(Mark One)

x Quarterly Report under Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarter ended March 31, 2007

or

 

¨ Transition Report under Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from              to             

000-13118

(Commission File No.)

 


ACTION PRODUCTS INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

 


 

Florida   59-2095427

(State or other jurisdiction of

incorporation or organization)

 

(IRS Employer

Identification No.)

1101 North Keller Rd., Suite E, Orlando, Florida, 32810

(Address of principal executive offices, Zip Code)

Registrant’s telephone number, including area code (407) 481-8007

 


Check whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    YES  x    NO  ¨

Indicate by check mark whether registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act):    YES  ¨    NO  x

State the number of shares outstanding of each of the issuer’s classes of common stock, as of last practicable date.

 

Class

     

Outstanding at May 14, 2007

Common Stock, $.001 par value

    5,231,500

Transitional Small Business Disclosure Format (check one):    YES  ¨    NO  x

 



Table of Contents

INDEX

 

     Page
Number

PART I.  FINANCIAL INFORMATION

   3

Item 1. Financial Statements

   3

Condensed Balance Sheet at March 31, 2007 (unaudited)

   3

Condensed Statements of Operations - Three months ended March 31, 2007 and 2006 (unaudited)

   4

Condensed Statements of Cash Flows - Three months ended March 31, 2007 and 2006 (unaudited)

   5

Notes to Condensed Financial Statements (unaudited)

   6

Item 2. Management’s Discussion and Analysis or Plan of Operation

   10

Item 3. Controls and Procedures

   12

PART II. OTHER INFORMATION

   13

Item 2. Unregistered Sales of Securities and Use of Proceeds

   13

Item 5. Other Information

   13

Item 6. Exhibits

   13

SIGNATURE PAGE

   13

 

Page 2 of 15


Table of Contents

PART I. FINANCIAL INFORMATION

ITEM 1. Financial Statements

ACTION PRODUCTS INTERNATIONAL, INC.

CONDENSED BALANCE SHEET (Unaudited)

 

     March 31, 2007  
ASSETS   

CURRENT ASSETS

  

Cash and cash equivalents

   $ 473,100  

Investment securities

     725,000  

Accounts receivable, net of an allowance for doubtful accounts of $151,800

     1,182,000  

Inventories, net

     1,468,000  

Prepaid expenses and other assets

     239,700  
        

TOTAL CURRENT ASSETS

     4,087,800  

PROPERTY, PLANT AND EQUIPMENT

     3,625,500  

Less accumulated depreciation and amortization

     (2,628,900 )
        

NET PROPERTY, PLANT AND EQUIPMENT

     996,900  

GOODWILL

     1,405,300  

OTHER ASSETS

     77,500  
        

TOTAL ASSETS

   $ 6,567,200  
        
LIABILITIES AND SHAREHOLDERS’ EQUITY   

CURRENT LIABILITIES

  

Accounts payable

   $ 390,300  

Accrued expenses, payroll and related expenses

     806,500  

Current portion of mortgage payable

     20,800  

Borrowings under line of credit

     1,422,400  

Borrowings under investment account

     251,400  

Other current liabilities

     45,400  
        

TOTAL CURRENT LIABILITIES

     2,936,800  
        

TOTAL LIABILITIES

     2,936,800  
        

COMMITMENTS & CONTINGENCIES

  

SHAREHOLDERS’ EQUITY

  

Preferred Stock - 10,000,000 shares authorized, zero shares issued and outstanding

     —    

Common stock - $.001 par value; 15,000,000 shares authorized; 5,435,000 shares issued

     5,400  

Treasury Stock - $.001 par value; 203,500 shares

     (200 )

Additional paid-in capital

     8,958,000  

Unearned compensation cost

     (5,600 )

Accumulated deficit

     (5,327,200 )
        

TOTAL SHAREHOLDERS’ EQUITY

     3,630,400  
        

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

   $ 6,567,200  
        

See Accompanying Notes

 

Page 3 of 15


Table of Contents

ITEM 1. Financial Statements (cont.)

ACTION PRODUCTS INTERNATIONAL, INC.

CONDENSED STATEMENTS OF OPERATIONS (Unaudited)

 

     Three Months Ended March 31  
     2007     2006  

NET SALES

   $ 1,369,200     $ 1,635,700  

COST OF SALES

     778,000       848,200  
                

GROSS PROFIT

     591,200       787,500  

OPERATING EXPENSES

    

Selling

     478,100       613,400  

General and administrative

     678,900       808,000  
                

TOTAL OPERATING EXPENSES

     1,157,000       1,421,400  
                

LOSS FROM OPERATIONS

     (565,800 )     (633,900 )

OTHER INCOME (EXPENSE)

    

Interest expense

     (22,400 )     (9,200 )

Other, net

     39,400       57,300  
                
     17,000       48,100  
                

LOSS BEFORE INCOME TAXES

     (548,800 )     (585,800 )

INCOME TAXES

     —         —    
                

NET LOSS

   $ (548,800 )   $ (585,800 )
                

LOSS PER SHARE

    

Basic and Diluted

   $ (0.10 )   $ (0.11 )
                

Weighted average number of common shares outstanding:

    

Basic and Diluted

     5,231,500       5,197,200  
                

See Accompanying Notes

 

Page 4 of 15


Table of Contents

ITEM 1. Financial Statements (cont.)

ACTION PRODUCTS INTERNATIONAL, INC.

CONDENSED STATEMENTS OF CASH FLOWS (Unaudited)

 

     Three Months Ended March 31  
     2007     2006  

CASH FLOWS FROM OPERATING ACTIVITIES

    

Net Loss

   $ (548,800 )   $ (585,800 )

Adjustments to reconcile net loss to net cash provided by (used in) operating activities

    

Depreciation

     44,600       66,900  

Amortization

     5.900       22,700  

Unrealized (gains) losses on investment securities

     17,800       (10,000 )

Stock based compensation expense

     12,500       65,600  

Provision for bad debts

     (8,300 )     106,900  

Provision for inventory reserve

     (93,200 )     8,400  

(Gain) loss on disposal of other assets

     52,400       —    

Changes in:

    

Accounts receivable

     740,100       522,600  

Investment securities

     (585,800 )     65,000  

Inventories

     170,600       96,100  

Prepaid expenses

     23,500       (53,500 )

Other assets

     (39,600 )     9,000  

Accounts payable

     (78,900 )     39,800  

Accrued expenses, payroll and related expenses

     (36,100 )     4,300  

Deferred revenue

     (6,200 )     (6,200 )
                

NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES

     (329,600 )     351,800  
                

CASH FLOWS FROM INVESTING ACTIVITIES

    

Acquisition of property, plant and equipment

     (41,500 )     (18,500 )
                

NET CASH USED IN INVESTING ACTIVITIES

     (41,500 )     (18,500 )
                

CASH FLOWS FROM FINANCING ACTIVITIES

    

Repayment of mortgage principal

     (20,300 )     (16,300 )

Common stock options and warrant issuance costs

     (800 )     (15,300 )

Net change in borrowings under line of credit

     244,000       (346,200 )

Net change in borrowings under investment account

     251,400       —    
                

NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES

     474,300       (377,800 )
                

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

     103,200       (44,500 )

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD

     369,900       223,400  
                

CASH AND CASH EQUIVALENTS AT END OF PERIOD

   $ 473,100     $ 178,900  
                

Supplemental disclosures - cash paid for:

    

Interest

   $ 1,000     $ 8,800  

Income Taxes

     —         —    

See Accompanying Notes

 

Page 5 of 15


Table of Contents

ACTION PRODUCTS INTERNATIONAL, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)

 

1. Condensed financial statements. In the opinion of management, the accompanying unaudited condensed financial statements contain all normal recurring adjustments necessary to present fairly the financial position of Action Products International, Inc. (the “Company”), at March 31, 2007 and the results of its (i) operations for the three month periods ended March 31, 2007 and 2006 and (ii) cash flows for the three month periods ended March 31, 2007 and 2006. The financial information included herein is taken from the books and records of the Company and is unaudited.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted. These condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s annual report on Form 10-KSB for the year ended December 31, 2006. The results of operations for the three-month period ended March 31, 2007 are not necessarily indicative of the operating results for the full year. Through March 31, 2007, the Company has been able to meet its obligations as they come due; however, it is at least reasonably possible that if the Company continues to incur losses and negative cash flows, it will have to obtain additional sources of debt or equity financing to maintain its liquidity (See Note 3). There can be no assurance that such financing will be available or available on terms acceptable to the Company, if needed.

 

2. Operations. The Company incurred significant losses in the current quarter. In its effort to eliminate these losses, the company has recently changed certain key members of management, has focused efforts on reducing overhead and operation costs, and is evaluating its product lines for proper margin contributions. Management believes that it will be successful in its plans to return the Company to profitability: accordingly, no adjustments have been made to the accompanying financials that might be necessary if the Company were unable to return to profitable operations.

 

3. Line of credit. The Company maintains a working capital line of credit with a financial institution. The agreement stipulates, among other things, a borrowing limit of the lesser of $2,500,000 or the sum of 85% of eligible accounts receivable and 50% of eligible inventory, as further defined in the agreement. Borrowings are collateralized by all accounts receivable and inventories. Interest is payable at the financial institution’s prime rate plus 150 basis points (institution’s prime rate was 8.25% at March 31, 2007). The agreement also requires, among other things, that the Company maintain certain financial ratios. The current term of the agreement expired April 30, 2007. At March 31, 2007, the Company was not in compliance with the debt service coverage covenant and had $1,422,400 of borrowings outstanding under the line of credit. The Company has been in negotiations with several lenders to replace the current financial institution. As of May 14, 2007 we have signed a non-binding term sheet with one of those lenders to replace the current line of credit. The proposed new line of credit will, if and when it closes, provide, among other matters, for a borrowing limit of the lesser of $2,000,000 or the sum of 85% of eligible accounts receivable and 50% of eligible inventory, as to be defined in the definitive agreement at an annual interest rate of prime plus 75 basis points. Borrowings will be secured by substantially all of the assets of the Company, including accounts receivable, inventory and owned real estate.

 

4. Borrowings under Investment Account. As part of the normal arrangement with the broker handling our marketable securities investments, the Company has the opportunity to borrow for investment when appropriate under a margin arrangement. The balance on the borrowing is secured by the securities in the portfolio and interest is charged at a variable rate on the average balance. The rate at March 31, 2007 was 7.25 percent.

 

Page 6 of 15


Table of Contents

NOTES TO CONDENSED FINANCIAL STATEMENTS (Continued)

 

5. Mortgage Payable. In November 1998, the Company borrowed $750,000 in the form of a mortgage payable. The mortgage is collateralized by real estate and improvements and contains certain restrictive covenants, which provide that, among other things, the Company maintain a minimum working capital, net worth, debt service coverage and a maximum debt to net worth ratio. At March 31, 2007, the company was not in compliance with the debt service coverage and maximum debt to worth ratio covenants. The balance due under the mortgage payable is $20,800.

 

6. Earnings (loss) per share. Common stock equivalents were not included in the computation of diluted earnings (loss) per share for the three-month periods ended March 31, 2007 and 2006, as their effect would have been anti-dilutive. Common share equivalents excluded from the diluted earnings per share computations were 7,137,600 and 7,620,300 for the three months ended March 31, 2007 and March 31, 2006 respectively.

 

7. Common Stock and Equity Securities. On March 30, 2004, the Company announced that the Board of Directors had authorized a program for repurchases of up to 150,000 shares of common stock. The repurchased shares will be held in the treasury. The Company did not repurchase any shares of its common stock during the first quarter of 2007.

In 2003, the Company’s shareholders were issued one warrant for each share of common stock owned as of June 12, 2003, the record date. Each warrant entitles the holder to purchase one common share at an exercise price of $2.00. On June 6, 2006, the Company’s Board of Directors extended the expiration date of the warrants from June 9, 2006 to December 31, 2010. All other terms of the warrants remain the same. As of March 31, 2007 approximately 3,272,100 warrants had been issued and 1,566,700 had been exercised.

In 2005, the Company’s shareholders were issued one warrant for each share of common stock owned as of January 7, 2005, the record date. Each warrant entitled the holder to purchase one common share at exercise prices of $3.00 and $3.50 and expired January 6, 2006. As of the expiration date, approximately 4,636,900 warrants had been issued, total warrants exercised were 466,800.

In 2006, the Company’s shareholders were issued one warrant for each share of common stock owned as of January 18, 2006, the record date. Each warrant entitles the holder to purchase one common share at exercise prices of $3.25 and $3.75. On January 31, 2007, the Company’s Board of Directors extended the expiration dates of the warrants from January 31, 2007 to January 31, 2008 at $3.25 per share and from February 1, 2008 to December 31, 2010 at $3.75 per share As of March 31, 2007 5,197,200 warrants had been issued and none had been exercised.

Share-Based Compensation. The company has a stock-based employee compensation plan (the “Plan”) that provides incentives through the grant of stock options. The exercise price of stock options granted under the Plan shall not be less than the fair market value of the shares on the date of grant. As of March 31, 2007, 1,400,000 shares of common stock are reserved for issuance under the Plan.

On January 1, 2006, the Company adopted the provisions of Financial Accounting Standards Board Statement No. 123R, “Share-Based Payment” (SFAS 123R). SFAS 123R revised SFAS 123, “Accounting for Stock Based Compensation” and supersedes APB Opinion No. 25, “Accounting for Stock Issued to Employees.” SFAS 123R requires companies to measure and recognize compensation expense for all employee stock-based payments at fair value over the service period underlying the arrangement. Therefore, the Company is now required to record the grant-date fair value of its graded vesting employee stock-based payments (i.e., stock options and other equity-based compensation) in the statement of operations. The Company adopted FAS 123R using the “modified prospective” method, whereby fair value of all previously-granted employee stock-based arrangements that remained unvested at January 1, 2006 and all grants made on or after January 1, 2006 will be included in the Company’s determination of stock-based compensation expense over the remaining vesting period of the underlying options.

 

Page 7 of 15


Table of Contents

NOTES TO CONDENSED FINANCIAL STATEMENTS (Continued)

Common Stock and Equity Securities (cont.)

The fair value of each employee and director grant of options to purchase common stock is estimated on the date of the grant using the Black-Scholes option-pricing model. The fair value of restricted common stock grants is measured based upon the quoted market price of the Company’s common stock on the date of grant. On March 31, 2007 we had one share-based compensation plan. The compensation costs charged as operating expense for grants under the plan were approximately $12,500 and $65,600 for the three months ended March 31, 2007 and March 31, 2006 respectively.

During the quarter ended March 31, 2007 we did not grant any shares of restricted common stock and we did not grant any options to purchase common stock, to employees and directors of the Company. A summary of option activity under the plan as of March 31, 2007, and changes during the three months then ended are presented below:

 

Options

   Number of
Options
    Weighted-
Average
Exercise Price
   Weighted-
Average
Remaining
Contractual Term
   Weighted-
Average
Grant Date Fair
Value

Outstanding at January 1, 2007

   255,000     $ 3.22    2.1    $ 1.95

Grants

   —       $ —        

Exercises

   —       $ —        

Cancellations

   (20,000 )   $ 1.36      
              

Outstanding at March 31, 2007

   235,000     $ 3.41    5.2    $ 1.83
              

Shares exercisable at March 31, 2007

   217,000     $ 3.37    1.5    $ 1.75
              

As of March 31, 2007 there was approximately $5,600 of total unrecognized compensation cost related to non-vested share-based compensation arrangements (options) granted under the plan. That cost is expected to be recognized over the next two quarters.

 

8. Marketable Securities. Marketable securities are categorized as trading securities and stated at market value. Market value is determined using the quoted closing or latest bid prices. Realized gains and losses on investment transactions are determined by specific identification and are recognized as incurred in the statement of income. Net unrealized gains and losses are reported in the statement of income and represent the change in market value of investment holdings during the period. At March 31, 2007 marketable securities consisted of the following:.

 

     Value At March 31,
2007
    Cumulative Unrealized Gain(Loss) At
March 31, 2007
 

Equity Securities

   $ 725,000     $ (58,600 )

Stock Options

   $ (24,100 )   $ 12,200  

Total

   $ 700,900     $ (46,400 )

 

9. Related Party Transactions. During the three months ended March 31, 2007 and 2006, the Company paid $11,300 and $11,300, respectively, to Warren Kaplan and $25,100 and $28,700, respectively, to Ronel Management Company, wholly owned by Warren Kaplan, former Chairperson of the Board and Judith Kaplan, former Board member for consulting services.

 

Page 8 of 15


Table of Contents

NOTES TO CONDENSED FINANCIAL STATEMENTS (Continued)

 

10. Other Commitments. In January 2006, the Company renewed its License Agreement (the “Agreement”) with Porchlight Entertainment, Inc., for the rights to market certain toy lines including a wooden adventure system and die cast metal collection under the Jay Jay The Jet Plane™ name. The term of the Agreement is for two years expiring on December 31, 2008, subject to the Company meeting certain minimum sales objectives and royalty requirements.

 

Page 9 of 15


Table of Contents

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-looking Statements:

Forward-looking statements in this Form 10-QSB including, without limitation, statements relating to our plans, strategies, objectives, expectations, intentions and adequacy of resources, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements made in this report, other than statements of historical fact, are forward-looking statements. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. The following factors, among others, could cause actual results to differ materially from those set forth in the forward-looking statements — our ability to successfully develop our brands and proprietary products through internal development, licensing and/or mergers and acquisitions. Additional factors include, but are not limited, the size and growth of the market for our products, competition, pricing pressures, market acceptance of our products, the effect of economic conditions, intellectual property rights, the results of financing efforts, risks in product development and other risks identified in this report and our other periodic filings with the Securities and Exchange Commission.

Results of Operations:

Three Months Ended March 31, 2007 Compared With Three Months Ended March 31, 2006

The following should be read in conjunction with our financial statements and the related notes thereto included elsewhere herein. The following table sets forth, as a percentage of sales, certain items appearing in our statements of operations.

 

     Quarter Ended March 31, 2007     Quarter Ended March 31, 2006  

Net Sales

   100.0 %   100.0 %

Cost of Sales

   56.8 %   51.9 %

Gross Profit

   43.2 %   48.1 %

Selling Expense

   34.9 %   37.5 %

General and Administrative Expense

   49.6 %   49.4 %

Total Operating Expense

   84.5 %   86.9 %

Loss from Operations

   (41.3 )%   (38.7 )%

Other Income (Expense)

   1.2 %   2.9 %

Loss before income taxes

   (40.1 )%   (35.8 )%

Taxes

   —       —    

Net Loss

   (40.1 )%   (35.8 )%

Net sales for the three months ended March 31, 2007 were $1,369,200 compared with net sales of $1,635,700 for the three months ended March 31, 2006. Management attributes much of the $266,500 or 16.3% decrease in net sales to a lack of specific inventory availability to meet customer order demand.

Gross profit decreased by $196,300 to $591,200 for the three months ended March 31, 2007, compared with $787,500 for the three months ended March 31, 2006. The gross profit percentage decreased from 48.1% to 43.2% for the three-month periods ended March 31, 2006 and 2007 respectively. The decrease in gross profit percentage was mainly attributable to adjusting inventory mix to match planned product sales. Certain quantities of slow moving product were sold at approximately the net realizable values previously recorded.

Selling, general and administrative (SG&A) expenses decreased by $264,400 to $1,157,000 for the three-month period ended March 31, 2007 from $1,421,400 for the three-month period ended March 31, 2006. This 18.6% decrease in SG&A expenses is due primarily to the following:

 

   

A decrease in compensation and related benefit costs of $149,500 principally as the result of the elimination of several positions. This decrease was partially offset by an increase of $46,000 in professional services.

 

Page 10 of 15


Table of Contents

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations (Continued)

 

   

A decrease in bad debt expense of $106,900

 

   

A decrease in business travel of $42,600

 

   

An increase in advertising and promotion of $30,000

Interest expense related to current and long-term debt was $22,400 and $9,200 for the three-month periods ended March 31, 2007 and 2006, respectively. The $13,200 increase was principally due to the higher borrowings under the line of credit and an increase in prime lending rate.

Other income and (expense), net during the three-month periods ended March 31, 2007 and 2006 was $39,400 and $57,300, respectively. The $17,900 change was mainly attributable to lower net gains from investments.

Loss before income taxes and net loss, as a result of the foregoing, was $548,800 for the three months ended March 31, 2007, compared with $585,800 for the three months ended March 31, 2006.

Financial Condition, Liquidity, and Capital Resources:

As of March 31, 2007, we had cash and cash equivalents of $473,100, representing a increase of $103,200 compared to December 31, 2006.

After taking account of non-cash items and other adjustments, our cash used in operations for the three months ended March 31, 2007 were $329,600. The principal source of cash from operating activities for the three months ended March 31, 2007 was from a net decrease of accounts receivable of $740,100 and a net decrease of inventory of $170,600. The principal use of cash from operating activities in the same period was a $585,800 increase in investment securities.

The principle use of cash from investing activities was $41,500 for several molds for product production.

After obtaining $244,000 by an increase in borrowings under our line of credit and $251,400 from borrowings under our margin account, $20,300 was used to repay mortgage principal and $800 related to expenses incurred in connection with warrant offerings. This resulted in net cash provided from financing activities of $474,300.

At March 31, 2007, borrowing under our line of credit was $1,422,400, an increase of $244,000 from $1,178,400 as of December 31, 2006. Our line of credit provides for borrowings up to $2,500,000 at the prime rate plus 150 basis points and matured April 30, 2007. As of May 14, 2007 we have signed a non-binding term sheet with a national lending institution to replace the current line of credit. Borrowings will be secured by substantially all of the assets of the Company, including accounts receivable, inventory and owned real estate

 

Page 11 of 15


Table of Contents

ITEM 3. Controls and Procedures

As of the end of the period covered by this report, our Company conducted an evaluation, under the supervision and with the participation of our chief executive officer and chief financial officer, of our disclosure controls and procedures (as defined in Rules 13a-15(e) of the Exchange Act). Based on this evaluation, our chief executive officer and chief financial officer concluded that our company’s disclosure controls and procedures are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms.

There was no change in our internal controls, which are included within disclosure controls and procedures, during our most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal controls.

 

Page 12 of 15


Table of Contents

PART II. OTHER INFORMATION

ITEM 2. Unregistered Sales of Securities and Use of Proceeds

Repurchase of Securities

On March 24, 2004, our Board of Directors authorized effective immediately, a program to repurchase up to 150,000 of our outstanding common shares. Repurchases may be made by us from time to time in the open market at prevailing prices, in either block purchases or in privately negotiated transactions. The share repurchase program expired March 24, 2007, three years from the date of authorization. We did not purchase any of our common shares for the quarter ending March 31, 2007. We repurchased a total of 30,701 of our common shares under the program.

ITEM 5. Other Information

 

(a) None.

 

(b) None.

ITEM 6. Exhibits and Reports on Form 8-K

A. Exhibits

 

Exhibit No.  

Description

31.1   Sarbanes-Oxley Act Section 302 Certification
32.1   Sarbanes-Oxley Act Section 906 Certification

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  ACTION PRODUCTS INTERNATIONAL, INC.
Date: May 14, 2007   By:  

/s/ RONALD S. KAPLAN

    Ronald S. Kaplan
    Chief Executive Officer (Principal Executive Officer)
    Chief Financial Officer (Principal Accounting Officer)

 

Page 13 of 15